切换至 "中华医学电子期刊资源库"

中华腔镜外科杂志(电子版) ›› 2022, Vol. 15 ›› Issue (06): 368 -371. doi: 10.3877/cma.j.issn.1674-6899.2022.06.010

短篇论著

阴式广泛联合经阴道内镜腹膜外淋巴结切除术
周灿坤1, 李庆东1, 江卓飞1, 肇丽杰1, 郑玉华1, 柳晓春1, 谢庆煌1, 黄晓斌1,()   
  1. 1. 528000 佛山市妇幼保健院妇科
  • 收稿日期:2022-12-06 出版日期:2022-12-30
  • 通信作者: 黄晓斌
  • 基金资助:
    佛山市科技创新项目(2020001005656); 佛山市经自然腔道手术发展与创新工程技术研究中心(2020001003507)

Vaginal radical hysterectomy combined with transvaginal endoscopic extraperitoneal lymph node dissection

Cankun Zhou1, Qingdong Li1, Zhuofei Jiang1, Lijie Zhao1, Yuhua Zheng1, Xiaochun Liu1, Qinghuang Xie1, Xiaobin Huang1,()   

  1. 1. Foshan Women and Children Hospital, Foshan 528000, China
  • Received:2022-12-06 Published:2022-12-30
  • Corresponding author: Xiaobin Huang
目的

探索经阴道广泛子宫切除术(laparoscopically assisted radical vaginal hysterectomy,LARVH)联合经阴道内镜腹膜外淋巴结切除术治疗早期宫颈癌的可行性。

方法

回顾性分析2019年7月至2021年12月在佛山市妇幼保健院妇科完成治疗的3例完全经阴道途径手术的早期宫颈癌患者的临床资料及随访结果。

结果

2例采用LARVH联合经阴道内镜腹膜外盆腔淋巴结切除术、1例采用经阴道宫颈广泛切除术联合经阴道内镜腹膜外盆腔淋巴结切除术。平均手术时间246.66 min,其中盆腔淋巴结清扫部分的平均手术时间172.33 min;平均术中出血量123.33 ml,无术中并发症;3例盆腔淋巴结切除数目分别为26、21、14枚,均在术后2 d肛门恢复排气,术后2例出现盆腔淋巴囊肿。术后最长随访时间3年,无复发、死亡。

结论

LARVH联合经阴道内镜腹膜外淋巴结切除术治疗早期宫颈癌是可行、安全的。

Objective

To explore the feasibility and safety of vaginal radical hysterectomy combined with transvaginal endoscopic extraperitoneal lymph node dissection(vNOTES Assisted VRH) for early-stage cervical cancer.

Methods

Retrospectively analyzed three cases with early-stage cervical cancer treated with vNOTES Assisted VRH in the Department of Gynecology, Foshan Women and Children Hospital.

Results

Vaginal radical hysterectomy combined with transvaginal endoscopic extraperitoneal lymph node dissection was performed in two patients early-stage cervical cancer, vaginal radical trachelectomy combined with transvaginal endoscopic extraperitoneal lymph node dissection was performanced in one case. The average operative time was 246.66 minutes, including an average of 172.33 minutes for the pelvic lymph node dissection, with an average operative blood loss of 123.33 ml. There were no intraoperative complications. Postoperative pathology confirmed that the number of resected pelvic lymph nodes were 26, 21, and 14, respectively. All patients recovered anal exhaust on the second day after operation. 2 patients developed postoperative pelvic lymphatic cysts. No recurrence or death within 3 years of post-operative follow-up.

Conclusions

vNOTES Assisted VRH is feasible and safe for the treatment of early-stage cervical cancer, but more studies are needed to prove it.

表1 三例早期宫颈癌患者资料
图1 经阴道广泛子宫切除术联合经阴道内镜腹膜外淋巴结切除术的主要操作步骤注:A.阴道"袖套";B.分离耻骨降支后方间隙;C.建立腹腔外空间;D.寻找解剖学标记;E.传统LN顺序范围;F.阴式广泛子宫切除
表2 三例早期宫颈癌患者随访资料
1
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin, 2018, 68(6):394-424.
2
Qiu H, Cao S, Xu R. Cancer incidence, mortality, and burden in china:a time-trend analysis and comparison with the united states and united kingdom based on the global epidemiological data released in 2020 [J]. Cancer Commun (Lond), 2021, 41(10) :1037-1048.
3
Zhang S, Wang S, Lv A, et al. Laparoscopically assisted radical vaginal hysterectomy for early-stage cervical cancer:a systemic review and meta-analysis [J]. Int J Gynecol Cancer, 2016, 26(8):1497-1502.
4
Torné A, Pahisa J, Ordi J, et al. Oncological results of laparoscopically assisted radical vaginal hysterectomy in early-stage cervical cancer:should we really abandon minimally invasive surgery[J]. Cancers (Basel), 2021, 13(4) :846.
5
谢庆煌,柳晓春,郑玉华,等. 经阴道子宫广泛切除联合腹腔镜手术治疗子宫恶性肿瘤的临床研究[J]. 实用妇产科杂志200723(1) :20-22.
6
Kalloo AN, Singh VK, Jagannath SB, et al. Flexible transgastric peritoneoscopy:a novel approach to diagnostic and therapeutic interventions in the peritoneal cavity [J]. Gastrointest Endosc, 2004, 60(1) :114-117.
7
Boruta DM. Laparoendoscopic single-site surgery in gynecologic oncology: an update [J]. Gynecol Oncol, 2016, 141(3): 616-623.
8
孙大为,张俊吉,熊巍,等.单孔腹腔镜下子宫内膜癌分期手术的临床报告 [J/CD].中华腔镜外科杂志(电子版)20147(1):10-13.
9
王延洲,陈诚,徐嘉莉,等. "筷子法"单孔腹腔镜技术在宫颈癌中的应用[J/CD].中华腔镜外科杂志(电子版)201811(1):28-31.
10
Lee CL, Wu KY, Su H, et al. Hysterectomy by transvaginal natural orifice transluminal endoscopic surgery (NOTES): a series of 137 patients [J]. J Minim Invasive Gynecol, 2014, 21(5): 818-824.
11
Li CB, Hua KQ. Transvaginal natural orifice transluminal endoscopic surgery (vNOTES) in gynecologic surgeries: a systematic review [J]. Asian J Surg, 2020, 43(1): 44-51.
12
Baekelandt JF. New retroperitoneal transvaginal natural orifice transluminal endoscopic surgery approach to sentinel node for endometrial cancer: a demonstration video [J]. J Minim Invasive Gynecol, 2019, 26(7): 1231-1232.
13
Hurni Y, Huber DE. Sentinel node biopsy by transvaginal natural orifice transluminal endoscopic surgery in a patient with early-stage cervical cancer: a case report[J]. Case Rep Oncol, 2022, 15(2): 547-452.
14
肇丽杰,柳晓春,谢庆煌,等.阴式广泛全子宫切除加腹腔镜下淋巴结切除术与开腹手术治疗早期宫颈癌疗效比较[J].中国实用妇科与产科杂志201228(6):432-434.
15
黄晓斌,谢庆煌,柳晓春,等.单孔腹腔镜盆腔淋巴结切除联合阴式广泛子宫切除术治疗早期宫颈癌[J].中国微创外科杂志201919(6):512-514.
16
Wang Y, Deng L, Tang S, et al. vNOTES hysterectomy with sentinel lymph node mapping for endometrial cancer: description of technique and perioperative outcomes [J]. J Minim Invasive Gynecol, 2021, 28(6): 1254-1261.
17
Mat E, Kale A, Gundogdu EC, et al. Transvaginal natural orifice endoscopic surgery for extremely obese patients with early-stage endometrial cancer [J]. J Obstet Gynaecol Res, 2021, 47(1): 262-269.
[1] 王一然, 王平. 《巴西肿瘤外科协会盆腔廓清术治疗宫颈癌指南》解读[J]. 中华妇幼临床医学杂志(电子版), 2021, 17(02): 142-151.
[2] 郑晓霞, 李大鹏. 中性粒细胞计数与淋巴细胞计数比值对局部晚期宫颈癌患者新辅助化疗疗效的预测价值[J]. 中华妇幼临床医学杂志(电子版), 2020, 16(05): 558-566.
[3] 刘云玥, 范文生, 顾成磊, 马鑫, 刘洪一, 孟元光. 达芬奇机器人MDT模式全盆腔廓清术治疗晚期宫颈癌一例[J]. 中华腔镜外科杂志(电子版), 2022, 15(04): 249-251.
[4] 张婷, 秦珊珊, 郁胜胜, 于鹃鹏, 宋禹辰, 高迎春. 腹腔镜子宫深静脉入路宫颈癌根治术[J]. 中华腔镜外科杂志(电子版), 2021, 14(06): 363-364.
[5] 苏英杰, 窦磊, 田东立, 芦恩婷, 张颐. 全脏器反位患者机器人辅助下宫颈癌根治术一例[J]. 中华腔镜外科杂志(电子版), 2021, 14(04): 245-247.
[6] 潘玉英, 孙力, 王桂香, 李华, 杨萌. 腹腔镜手术治疗宫颈癌复发一例[J]. 中华腔镜外科杂志(电子版), 2021, 14(01): 53-57.
[7] 马丽芳, 邹冬玲, 周琦. 达芬奇机器人辅助腹主动脉旁淋巴结切除术在宫颈癌分期术中的应用[J]. 中华腔镜外科杂志(电子版), 2020, 13(05): 278-282.
[8] 郭静, 齐卫红. circ_0000218通过靶向吸附miR-1182对宫颈癌HeLa细胞增殖、迁移和侵袭的影响[J]. 中华细胞与干细胞杂志(电子版), 2021, 11(02): 113-119.
[9] 廖欣, 顾一平, 廖薇. 低强度超声对HeLa肿瘤细胞凋亡的诱导作用及其机制[J]. 中华细胞与干细胞杂志(电子版), 2020, 10(05): 277-282.
[10] 首泉, 王茜, 谭志远. miR-98-5p靶向PYGO2基因对宫颈癌细胞增殖、迁移和侵袭的影响及其作用机制研究[J]. 中华细胞与干细胞杂志(电子版), 2020, 10(03): 138-145.
[11] 李红芳, 赵小环, 王丽萍, 许晓燕, 孙高高. 子宫颈癌细胞学新型生物标志、诊断标志物的筛选和开发现状[J]. 中华细胞与干细胞杂志(电子版), 2019, 09(06): 375-384.
[12] 刘萍, 潘九林. 补救性放化疗对宫颈癌术后盆腔复发和未控患者的治疗价值[J]. 中华临床医师杂志(电子版), 2020, 14(04): 267-271.
[13] 段鸿鉴, 张建好, 韩新巍, 赵艳萍, 候宇虹, 杨杰, 闫肃, 秦胜东. 膀胱阴道瘘的个体化介入治疗方法分析[J]. 中华介入放射学电子杂志, 2022, 10(01): 45-49.
[14] 张悦, 顾福嘉. MDR1甲基化对宫颈癌介入栓塞化疗疗效的影响[J]. 中华介入放射学电子杂志, 2020, 08(01): 51-56.
[15] 车拴龙, 刘栋, 刘斯, 罗丕福. 人工智能技术在宫颈细胞筛查中的应用进展和挑战[J]. 中华临床实验室管理电子杂志, 2019, 07(04): 193-198.
阅读次数
全文


摘要